Opsidio

Recent Finacing

Convertible

Recent Raise

Undisclosed

Opsidio is a Bryn Mawr, PA biotech developing monoclonal antibodies for fibrotic and remodeling diseases (IPF, CKD, systemic sclerosis, severe asthma), preparing lead candidate for manufacturing and clinical trials.